Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NILVAD trial of nilvadipine in mild to moderate Alzheimer's disease
NL-OMON37208Phase 3Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nilvadipine in Alzheimer's disease (AD), sponsored by Radboud University Medical Center. Started Jun 2013; status: active, not recruiting.
02
Drugs
nilvadipine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NL-OMON37208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37208.